CLDN5 and psychiatric disorder: Of note, 15–25% of patients with 22q11DS have experienced psychiatric disorders, mainly schizophrenia, but almost half of the patients with 22q11DS with rs10314 (CLDN-5 expression level is further declined) have experienced schizophrenia [180, 191].